Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.22%

Amgen Inc. (AMGN)

-NasdaqGS
157.35 Down 3.09(1.93%) 4:00PM EDT
|After Hours : 158.20 Up 0.85 (0.54%) 7:51PM EDT
Add to Portfolio
Prev Close:160.44
Open:159.60
Bid:157.45 x 400
Ask:158.20 x 200
1y Target Est:179.78
Beta:0.63
Earnings Date:Jul 27 - Jul 31 (Est.)
Day's Range:155.83 - 159.60
52wk Range:114.93 - 173.60
Volume:4,205,346
Avg Vol (3m):3,304,800
Market Cap:119.64B
P/E (ttm):21.24
EPS (ttm):7.41
Div & Yield:3.16 (2.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AMGNDown 1.93%119.64B
JNJUp 0.02%280.49B
NVSUp 0.70%252.32B
TEVAUp 0.23%51.59B

Key Statistics

Forward P/E (1 yr):14.93
P/S (ttm):5.93
Ex-Dividend Date:12-May-15

Analysts

Annual EPS Est (Dec-15) :9.59
Quarterly EPS Est (Jun-15) :2.40
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback